PHARMENA SA

PHARMENA SA is a publicly traded specialty healthcare company that develops and markets innovative products based on a patented, physiological, natural active substance, 1-MNA (1-methylnicotinamide). The company's diversified portfolio covers indications including excessive hair loss, dandruff, mild/moderate acne, sunburns, skin allergies and anti-aging, while also engaging in developing new oral medicines for cardiovascular diseases and other disorders; its latest product release is Menavitin, a patented dietary supplement line of eight products (cardio, cholesterol, diabetix, vital, memory, liver, senior, endotelio) built around the unique 1-MNA molecule as a novel food ingredient.